What is Lifesci Capital’s Estimate for VERV Q2 Earnings?
Verve Therapeutics, Inc. (NASDAQ:VERV – Free Report) – Equities researchers at Lifesci Capital issued their Q2 2025 earnings estimates for shares of Verve Therapeutics in a report issued on Tuesday, June 17th. Lifesci Capital analyst C. Jubinville forecasts that the company will post earnings per share of ($0.71) for the quarter. Lifesci Capital has a […]
Verve Therapeutics, Inc. (NASDAQ:VERV – Free Report) – Equities researchers at Lifesci Capital issued their Q2 2025 earnings estimates for shares of Verve Therapeutics in a report issued on Tuesday, June 17th. Lifesci Capital analyst C. Jubinville forecasts that the company will post earnings per share of ($0.71) for the quarter. Lifesci Capital has a […]
